Skip to main content

Table 3 Correlation between biochemical and inflammatory markers in NMOSD patients and control group

From: The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder

 

NMOSD

control

Ln. IL-6 (pg/ml)

Ln.IL-17A(pg/ml)

Ln. IL-6 (pg/ml)

Ln.IL-17A(pg/ml)

rb

P-value

R

P-value

rb

P-value

r

P-value

Ln.insulin (μU/L)

0.32

0.03a

0.19

0.15

−0.05

0.75

−0.02

0.81

FBS (mg/dL)

0.11

0.54

0.003

0.98

0.07

0.66

0.16

0.10

Ln.TG (mg/dL)

0.34

0.02a

0.16

0.23

0.32

0.04a

0.34

0.001a

Ln.HDL (mg/dL)

−0.27

0.08

−0.02

0.88

−0.03

0.83

−0.06

0.56

LDL (mg/dL)

0.05

0.74

0.02

0.86

0.11

0.51

−0.008

0.93

Chol. (mg/dL)

0.003

0.98

0.03

0.84

0.16

0.34

0.10

0.32

Ln.AST (U/L)

0.12

0.44

0.19

0.18

−0.02

0.89

0.11

0.26

Ln.ALT (U/L)

−0.08

0.62

−0.03

0.81

0.06

0.73

−0.11

0.28

  1. a After adjusting with BMI, age and sex, there was constant significant correlation
  2. br: Pearson’s correlation was applied to determine the correlation between circulating markers and inflammatory markers in NMOSD patients and controls
  3. ALT alanine aminotransferase, SAT serum agglutination test, Chol total cholesterol, HDL high-density lipoprotein cholesterol, IL-6 interleukin −6, IL-17A interleukin-17A, LDL low-density lipoprotein, Ln natural log, TG triglyceride
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us